Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2006Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variantButler, L.; Centenera, M.; Neufing, P.; Buchanan, G.; Choong, C.; Ricciardelli, C.; Saint, K.; Lee, M.; Ochnik, A.; Yang, M.; Brown, M.; Tilley, W.
2011Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver diseaseEbrahimkhani, M.; Oakley, F.; Murphy, L.; Mann, J.; Moles, A.; Perugorria, M.; Ellis, E.; Lakey, A.; Burt, A.; Douglass, A.; Wright, M.; White, S.; Jaffre, F.; Maroteaux, L.; Mann, D.
2021The BMP antagonist Gremlin1 contributes to the development of cortical excitatory neurons, motor balance and fear responsesSuzuki, M.; Suzuki, N.; Wang, T.; Kobayashi, H.; Vrbanac, L.; Ng, J.Q.; Wright, J.A.; Lannagan, T.R.M.; Gieniec, K.A.; Lewis, M.; Ando, R.; Enomoto, A.; Koblar, S.; Thomas, P.; Worthley, D.L.; Woods, S.L.
2016Computational reconstruction of NFκB pathway interaction mechanisms during prostate cancerBörnigen, D.; Tyekucheva, S.; Wang, X.; Rider, J.R.; Lee, G.S.; Mucci, L.A.; Sweeney, C.; Huttenhower, C.; Przytycka, T.M.
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancerWeickhardt, A.; Price, T.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T.; Azad, A.; Skrinos, E.; Fluck, K.; Dobrovic, A.; Salemi, R.; Scott, A.; Mariadason, J.; Tebbutt, N.
2011Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progressionWang, Q.; Bailey, C.; Ng, C.; Tiffen, J.; Thoeng, A.; Minhas, V.; Lehman, M.; Hendy, S.; Buchanan, G.; Nelson, C.; Rasko, J.
2015Cabozantinib inhibits abiraterone's upregulation of IGFIR phosphorylation and enhances its anti-prostate cancer activityWang, X.; Huang, Y.; Christie, A.; Bowden, M.; Lee, G.; Kantoff, P.; Sweeney, C.